This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Plan paraffin CLOCK IHC around widespread nuclear staining, with high signal in Leydig cells (HPA tissue IHC). Start the catalog antibody at 2–5 μg/mL (datasheet: RP1082), and account for circadian changes in localisation when interpreting staining (UniProt).
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected localisation | Nuclear in tissue (HPA tissue IHC); cytoplasm possible (UniProt) | |
| Staining pattern | Widespread nuclear staining; high in Leydig cells (HPA tissue IHC) | |
| Antigen retrieval | Tris-EDTA pH 9.0 HIER, 95–98 °C, 20 min (rule: nuclear antigen) | |
| Positive control | Testis+4 more · see all | |
| Negative control | None in HPA (detected in all 45 tissues); use no-primary + isotype controls |
| Fixation | Keep fixation consistent across sections. (standard IHC practice; not target-specific) | |
| Caveat | Circadian phase may shift nuclear versus cytoplasmic signal (UniProt) | |
| Regulation | Circadian nuclear shuttling (UniProt) | |
| Isoform / epitope | No annotated isoforms; one intracellular 1–846 chain (UniProt) |
Compare the catalog antibody’s IHC-P protocol (datasheet) with one published liver IHC protocol for CLOCK (PMC5985434).
| Sample | Paraffin-embedded human thyroid carcinoma tissue; fixative not specified (datasheet M00064) |
| Fixation | Image fixative and duration unreported (datasheet M00064); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat-induced epitope retrieval in Tris-EDTA buffer, pH 9.0, 20 min at 95–98 °C (standard rule: nuclear antigen) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% normal serum of the secondary host, 30 min, room temperature (standard) |
| Primary antibody | Rabbit monoclonal (clone ACCH-3) anti-CLOCK, 1:50 (datasheet M00064) |
| Primary incubation | Overnight at 4 °C (standard) |
| Detection | HRP-polymer secondary, DAB chromogen 5–10 min (standard) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | CLOCK-positive staining in leydig cells of testis (HPA tissue IHC: High). HPA tissue profile: Ubiquitous nuclear expression. No signal in the no-primary control. |
CLOCK is predominantly nuclear in tissue IHC (HPA: ubiquitous nuclear expression; Supported reliability, with medium consistency against RNA data). Expect the clearest signal in testicular Leydig cells, where staining is High; several other listed cell populations show Medium staining (HPA: tissue IHC). Some cytoplasmic signal can be biologically plausible because CLOCK moves between nucleus and cytoplasm under circadian and BMAL1-dependent regulation (UniProt O15516: subcellular location). CLOCK has no transmembrane segment (UniProt O15516: topology).
| Distinct nuclear staining in Leydig cells; weaker nuclear staining across other tissues. | This fits the reported pattern: Leydig cells are High, while adipocytes and several glandular or neuronal cell populations are Medium (HPA: tissue IHC). Compare compartments and cell populations as well as intensity; the tissue profile is ubiquitous and has Supported reliability with medium RNA–staining consistency (HPA: tissue IHC). |
| Predominantly cytoplasmic staining, with little nuclear signal. | Review the slide before calling this artefact. CLOCK can shuttle between cytoplasm and nucleus; its phosphorylated form is nuclear, while its nonphosphorylated form is reported only in cytoplasm (UniProt O15516: subcellular location). A predominantly cytoplasmic tissue pattern differs from HPA’s ubiquitous nuclear IHC profile and merits antibody and detection controls (HPA: tissue IHC; general IHC practice). |
| Strong staining appears chiefly in an unexpected cell population. | Compare the actual cell identity with the HPA tissue profile before assigning specificity: Leydig cells are High, while several other listed populations are Medium or Low (HPA: tissue IHC). Unexpected staining could reflect antibody cross-reactivity or endogenous chromogenic activity; inspect controls and tissue morphology before interpreting it as CLOCK (general IHC practice). |
| Diffuse chromogen covers nuclei, cytoplasm, and tissue background. | A diffuse pattern cannot establish CLOCK localization against the reported nuclear tissue profile (HPA: tissue IHC). Excess primary antibody, incomplete blocking, endogenous detection activity, or nonspecific secondary binding are general IHC possibilities; a primary-omission control helps distinguish detection background from primary-dependent staining (general IHC practice). |
| No detectable staining in testicular Leydig cells. | This conflicts with the High Leydig-cell staining reported by HPA, but one negative section does not establish absence of CLOCK (HPA: tissue IHC). Check that Leydig cells are present, then review the antibody’s IHC validation, retrieval and detection conditions alongside an appropriate positive control (HPA: antibody validation; general IHC practice). |
| Circadian compartment changes | Nuclear-to-cytoplasmic distribution can vary with circadian regulation and BMAL1 dependence; record collection time when comparing experiments (UniProt O15516: subcellular location; general study-design practice). |
| Choice of reference tissue | Leydig cells provide a High-staining reference; small-intestinal glandular cells, cholangiocytes, and pancreatic exocrine cells are Low, not established negatives (HPA: tissue IHC). |
| Antibody evidence | Two listed rabbit polyclonal antibodies have Supported IHC status; HPA gives the tissue profile Supported reliability with medium RNA–staining consistency (HPA: antibody validation and tissue IHC). |
| Molecular location and processing | CLOCK has no transmembrane segment, signal peptide, or propeptide; the supplied record describes one chain spanning residues 1–846 (UniProt O15516: topology and processing). |
| Situation | Likely cause | Next action |
|---|---|---|
| Leydig-cell nuclei are blank. | The result disagrees with the High Leydig-cell reference; a failed IHC workflow or absence of identifiable Leydig cells remains possible (HPA: tissue IHC; general IHC practice). | Confirm tissue morphology and run a known-positive section; review the catalog antibody’s IHC-P instructions, including its specified retrieval and dilution, before adjusting the workflow (general IHC practice). |
| Only weak staining appears in a Low-listed population. | Low staining is reported for several populations, including small-intestinal glandular cells and cholangiocytes; these are poor sole checks for assay performance (HPA: tissue IHC). | Include a section with identifiable Leydig cells as the stronger reference and compare nuclear localization under the same staining run (HPA: High in Leydig cells; general IHC practice). |
| Chromogen is widespread or obscures cell boundaries. | Nonspecific antibody binding or endogenous detection activity can obscure a compartment-specific readout (general IHC practice). | Inspect a primary-omission control and review blocking, primary concentration, washes, and endogenous-enzyme controls as appropriate to the chromogenic system (general IHC practice). |
| The strongest signal is cytoplasmic. | Cytoplasmic CLOCK is plausible, but a chiefly cytoplasmic slide diverges from HPA’s ubiquitous nuclear tissue pattern (UniProt O15516: subcellular location; HPA: tissue IHC). | Check nuclear counterstain and morphology, compare control sections and collection times, and avoid scoring cytoplasmic intensity alone as confirmation of specific staining (general IHC practice; UniProt O15516: circadian shuttling). |
| A different cell population stains strongly. | CLOCK expression is broad, but the observed population may differ from the listed HPA pattern; cross-reactivity or endogenous chromogenic activity also remains possible (HPA: tissue IHC; general IHC practice). | Identify the cells morphologically, compare their reported HPA level, and inspect primary-omission and other appropriate assay controls before assigning the signal to CLOCK (HPA: tissue IHC; general IHC practice). |
| What pattern should an IF/ICC image show? | The HPA ICC-IF summary places CLOCK mainly in the nucleoplasm and additionally in vesicles; this is a separate imaging context from paraffin-section IHC (HPA: subcellular ICC-IF). | Interpret an IF/ICC image against its own nuclear and vesicular reference pattern; do not use it to override the predominantly nuclear tissue-IHC profile (HPA: subcellular ICC-IF and tissue IHC). |
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Supported — Medium consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Testis | Leydig cells | High | Protein (IHC) | HPA → |
| Adipose tissue | Adipocytes | Medium | Protein (IHC) | HPA → |
| Adrenal gland | Glandular cells | Medium | Protein (IHC) | HPA → |
| Appendix | Glandular cells | Medium | Protein (IHC) | HPA → |
| Bone marrow | Hematopoietic cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| None in HPA: CLOCK is detected in all 45 scored tissues. Use a no-primary (secondary-only) and an isotype control instead. | ||||
Troubleshoot CLOCK staining in paraffin sections by checking retrieval, compartment, controls and sampling time before comparing chromogenic signal across specimens.
Anti-CLOCK IHC images cover paraffin-embedded human thyroid carcinoma, human cancer tissue, and mouse and rat brain (M00064 and RP1082 image captions); IF images cover HeLa and U2OS cells (M00064 and RP1082 image captions).
M00064 has an IHC image from paraffin-embedded human thyroid carcinoma and an IF image from HeLa cells; its listed reactivity is Human, Mouse, and Rat (M00064 image captions; catalog reactivity). RP1082 has IHC images from paraffin-embedded human cancer tissue, mouse brain, and rat brain, plus an IF image from U2OS cells (RP1082 image captions).
Which to pick: For tissue IHC, choose RP1082 if its documented paraffin-section workflow is useful: its captions specify EDTA retrieval at pH 8.0 and 2 μg/ml primary antibody, but do not report the fixative (RP1082 IHC image captions). For IF/ICC, M00064 offers a rabbit monoclonal with a HeLa IF image; its IHC caption shows a paraffin-embedded section but does not report the fixative (M00064 catalog clone and applications; M00064 image captions). For cross-species planning, RP1082 lists Human, Monkey, Mouse, and Rat reactivity, while its IHC images document human, mouse, and rat tissues (RP1082 catalog reactivity; RP1082 IHC image captions).